Fenoldopam: Potential clinical applications in heart surgery;Fenoldopam: Potenciales aplicaciones clínicas en pacientes intervenidos de cirugía cardíaca

Revista Espanola de Anestesiologia y Reanimacion

Volumn 48, Issue 10, 2001, Pages 487-491

  Shorten, G D ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Heart surgery; Pharmacology: Fenoldopam

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FENOLDOPAM;

CONFERENCE PAPER; DRUG EFFECT; HEART SURGERY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY TUBULE ABSORPTION; OXYGEN CONSUMPTION; SMOOTH MUSCLE RELAXATION; VASCULAR RESISTANCE; VASODILATATION;

ANTIHYPERTENSIVE AGENTS; CORONARY ARTERY BYPASS; DIURETICS; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; EXTRACORPOREAL CIRCULATION; FENOLDOPAM; HUMANS; HYPERTENSION; INTRAOPERATIVE COMPLICATIONS; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY TUBULAR NECROSIS, ACUTE; MESENTERY; MYOCARDIAL ISCHEMIA; NATRIURESIS; OXYGEN CONSUMPTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, DOPAMINE D1; RENAL ARTERY; RENAL CIRCULATION; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 14244273798     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Mangos GJ, Brown MA, Chan WYL, Horton D, Trew P, Whitworth JA. Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust NZ J Med 1995; 25: 284-289.
2. Sladen RN, Prough DS. Perioperative renal protection. Prob Anaesth 1997; 9: 314-331.
3. Taylor DE, Gutiérrez G. Tonometry: a review of clinical studies. Crit Care Clinics 1996; 12: 1007-1018.
4. Fiddian-Green RG, Baker S. Predictive value of stomach wall pH for complications after cardiac operations: comparison with other monitoring. Crit Care Med 1987; 15: 153-156.
5. Mythen MG, Webb AR. Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 1994; 20: 99-104.
6. Price HL, Deutsch S, Marshall BE, Stephen GW, Behar MG, Neufeld GR. Haemodynamic and metabolic effects of haemorrhage in man with particular reference to the splanchnic circulation. Circ Res 1966; 18: 469-474.
7. Gilmour DG, Aitkenhead AR, Hothersall AP, Ledingham IM. The effect of hypovolaemia on colon blood flow in the dog. Br J Surg 1980; 67: 82-84.
8. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multi-organ failure. Arch Surg 1990; 125: 403-405.
9. Rush BF Jr, Sori AJ, Murphy TF, Smith S, Flanagan JJ Jr, Machiedo GW. Endotoxemia and bacteremia during hemorrhagic shock: The link between trauma and sepsis? Ann Surg 1988; 207: 549-554.
10. Ackerman DM, Blumberg AL, McCafferty JP, Sherman SS, Weinstock J, Kaiser C et al. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526. Fed Proc 1983; 42: 186-190.
11. Brogden RN, Markham A. Fenoldopam. A review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies. Drugs 1997; 54: 634-650.
12. 1 agonist fenoldopam. Circulation 1987; 76: 1312-1318.
13. Ruilope LM, Robles RG, Miranda B, Tovar J, Alcazar JM, Sancho J et al. Renal effects of fenoldopam in refractory hypertension. J Hypertens 1988; 6: 665-669.
14. Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J Clin Endocrinol Metab 1989; 69: 1116-1121.
15. Lappe RW, Todt JA, Wendt RL. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 1986; 236: 187-191.
16. Schiffer ER, Schwieger IM, Gosteli P, Poinsot O, Mentha G, Morel DR. Systemic and splanchnic oxygen supply-demand relationship with fenoldopam, dopamine and noradrenaline in sheep. Eur J Pharmacol 1995; 286: 49-60.
17. Gelman S. Renal protection during surgical stress. Acta Anaesthesiol Scand 1999; 110 (Supl): 43-45.
18. Goldberg LI, Kohli JD, Glock D. Conclusive evidence for two subtypes of peripheral dopamine receptors. En: Woodruff GN, Poat JA, Roberts PJ, editores. Dopaminergic systems and their regulation. Londres: MacMillan, 1986; 195-212.
19. Ozono R, O'Connell DP, Wang ZQ, Moore AF, Sanada H, Felder RA et al. Localisation of the dopamine D1 receptor protein in the human heart and kidney. Hypertension 1997; 30: 725-729.
20. Mathur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999; 27: 1832-1837.
21. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203.
22. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB et al. Effect of "Renal-Dose" dopamine on renal function following cardiac surgery. Anaesth Intens Care 1993; 21: 56-61.
23. Goldberg LI. Dopamine and new dopamine analogs: Receptors and clinical applications. J Clin Anesth 1988; 1: 66-74.
24. Schwartz L, Gewertz B. The renal response to low dose dopamine. J Surg Res 1988; 45: 574-588.
25. Olsen N, Bonde J, Kanstrup I, Plum I, Strandgaard S, Leyssac PP. Dopamine natriuresis in salt-depleted, water loaded humans: A dose response study. Br. Clin Pharmacol 1997; 43: 509-520.
26. Carey RM, Siragy HM, Ragsdale NV, Howell NL, Felder RA, Peach MJ et al. Dopamine-1 and dopamine-2 mechanisms in control of renal function. Am J Hypertens 1990; 3: S59-S63.
27. Girbes ARJ, Smit AJ, Meijer S, Reitsma WD. Renal and endocrine effects of fenoldopam and metoclopramide in normal man. Nephron 1990; 56: 179-185.
28. Palizas F, Doglio G, Gutiérrez G, Palizas F, Doglio G, Wainsztein N et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ll patients. Lancet 1992; 339: 195-199.
29. Gutiérrez G, Brown SD. Gastrointestinal tonometry: a monitor of regional dysoxia. New Horiz 1996; 4: 413-419.
30. Brown SD, Gutiérrez G. Does gastric tonometry work? Yes Crit Care Clin 1996; 12: 569-585.
31. Maynard N, Bihari D, Beale R, Smithies M, Baldock G, Mason R, McColl I. Assesment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993; 270: 1203-1210.
32. Marik PE. Gastric intramucosal pH: a better predictor of multiorgan dysfunction syncrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104; 225-229.
33. Mrozek R, Wos S, Bachowski R, Fryc J, Kucewicz E, Kruczak W et al. Gastric tonometry as a method of visceral oxygenation monitoring in patients undergoing coronary revascularisation. Eur J Cardiothorac Surg 1997; 11: 1158-1162.